Free Trial

BioSig Technologies Q1 2023 Earnings Report

BioSig Technologies logo
$1.13 -0.03 (-2.59%)
As of 03:58 PM Eastern

BioSig Technologies EPS Results

Actual EPS
-$1.20
Consensus EPS
-$1.00
Beat/Miss
Missed by -$0.20
One Year Ago EPS
N/A

BioSig Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
$0.14 million
Beat/Miss
Missed by -$130.00 thousand
YoY Revenue Growth
N/A

BioSig Technologies Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

BioSig Technologies Earnings Headlines

A simple pattern that works in any market
Right when most traders were getting bearish, The All-Weather Pattern signaled something different. Following this setup could've turned every $1,000 into $1,770 in just 48 hours. But here's what really gets me excited... You don't need to be glued to your screen all day, no complex formulas, no guessing. Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning. That's it. While of course I cannot promise future returns or against losses… I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week.
See More BioSig Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioSig Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioSig Technologies and other key companies, straight to your email.

About BioSig Technologies

BioSig Technologies (NASDAQ:BSGM), together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

View BioSig Technologies Profile

More Earnings Resources from MarketBeat